KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Free Cash Flow (2016 - 2025)

CareDx's Free Cash Flow history spans 13 years, with the latest figure at $22.1 million for Q4 2025.

  • For Q4 2025, Free Cash Flow fell 15.72% year-over-year to $22.1 million; the TTM value through Dec 2025 reached $38.8 million, up 3.76%, while the annual FY2025 figure was $38.8 million, 3.76% up from the prior year.
  • Free Cash Flow for Q4 2025 was $22.1 million at CareDx, down from $36.1 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $36.1 million in Q3 2025 and bottomed at -$34.9 million in Q1 2021.
  • The 5-year median for Free Cash Flow is -$2.2 million (2023), against an average of -$625850.0.
  • The largest YoY upside for Free Cash Flow was 1250.92% in 2024 against a maximum downside of 699.95% in 2024.
  • A 5-year view of Free Cash Flow shows it stood at $7.9 million in 2021, then tumbled by 50.68% to $3.9 million in 2022, then crashed by 158.29% to -$2.3 million in 2023, then soared by 1250.92% to $26.2 million in 2024, then decreased by 15.72% to $22.1 million in 2025.
  • Per Business Quant, the three most recent readings for CDNA's Free Cash Flow are $22.1 million (Q4 2025), $36.1 million (Q3 2025), and $8.9 million (Q2 2025).